Rocket Pharmaceuticals (RCKT) Short Interest Ratio & Short Volume $2.98 -0.11 (-3.40%) As of 10:32 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Rocket Pharmaceuticals Short Interest DataRocket Pharmaceuticals (RCKT) has a short interest of 12.90 million shares. This marks a -5.01% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.6, indicating that it would take 2.6 days of the average trading volume of 3.36 million shares to cover all short positions.Current Short Interest12,900,000 sharesPrevious Short Interest13,580,000 sharesChange Vs. Previous Month-5.01%Dollar Volume Sold Short$36.25 millionShort Interest Ratio2.6 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares106,790,000 sharesPercentage of Shares Shorted12.08%Today's Trading Volume588,271 sharesAverage Trading Volume3,358,171 sharesToday's Volume Vs. Average18% Short Selling Rocket Pharmaceuticals? Sign up to receive the latest short interest report for Rocket Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRCKT Short Interest Over TimeRCKT Days to Cover Over TimeRCKT Percentage of Float Shorted Over Time Rocket Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202512,900,000 shares $36.25 million -5.0%N/A2.6 $2.81 6/30/202513,580,000 shares $33.27 million -3.3%16.9%2.7 $2.45 6/15/202514,040,000 shares $41.14 million +11.0%17.5%2.8 $2.93 5/31/202512,650,000 shares $31.37 million -9.3%19.4%2.7 $2.48 5/15/202513,940,000 shares $93.68 million +13.7%21.4%3.8 $6.72 4/30/202512,260,000 shares $93.54 million -7.8%N/A4.9 $7.63 4/15/202513,300,000 shares $86.85 million +6.9%20.4%5.8 $6.53 3/31/202512,440,000 shares $82.97 million +12.6%19.1%6.3 $6.67 3/15/202511,050,000 shares $96.80 million +0.1%17.0%7.2 $8.76 2/28/202511,040,000 shares $104.33 million -1.8%16.9%7.3 $9.45 Get the Latest News and Ratings for RCKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rocket Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/202511,240,000 shares $117.68 million +6.8%17.2%7.8 $10.47 1/31/202510,520,000 shares $112.98 million -10.1%N/A7.4 $10.74 1/15/202511,700,000 shares $127.30 million -9.5%N/A9 $10.88 12/31/202412,930,000 shares $162.53 million +15.7%N/A11.3 $12.57 12/15/202411,180,000 shares $134.38 million +7.6%N/A10.4 $12.02 11/30/202410,390,000 shares $149.51 million -6.3%N/A11.2 $14.39 11/15/202411,090,000 shares $155.04 million -6.8%N/A12.1 $13.98 10/31/202411,900,000 shares $198.14 million +3.3%N/A14.3 $16.65 10/15/202411,520,000 shares $192.15 million +1.1%N/A13.5 $16.68 9/30/202411,400,000 shares $210.56 million +1.2%N/A13.1 $18.47 9/15/202411,260,000 shares $221.26 million +3.0%N/A13 $19.65 8/31/202410,930,000 shares $206.03 million +0.1%N/A13.1 $18.85 8/15/202410,920,000 shares $203.11 million +3.7%N/A13 $18.60 7/31/202410,530,000 shares $254.83 million +9.2%N/A13 $24.20 7/15/20249,640,000 shares $217.38 million +14.6%N/A12.1 $22.55 6/30/20248,410,000 shares $181.07 million -9.2%N/A10.7 $21.53 6/15/20249,260,000 shares $202.42 million -1.6%N/A13.1 $21.86 5/31/20249,410,000 shares $200.62 million -5.8%N/A14.2 $21.32 5/15/20249,990,000 shares $236.36 million +1.5%N/A14.6 $23.66 4/30/20249,840,000 shares $211.76 million -10.6%N/A13.5 $21.52 4/15/202411,000,000 shares $264.11 million +4.6%N/A15.3 $24.01 3/31/202410,520,000 shares $283.41 million +2.7%N/A14.7 $26.94 3/15/202410,240,000 shares $274.53 million +2.8%N/A13.6 $26.81 2/29/20249,960,000 shares $291.83 million +8.3%N/A12 $29.30 2/15/20249,200,000 shares $280.78 million +8.9%N/A11.3 $30.52 1/31/20248,450,000 shares $242.77 million +2.4%N/A10.4 $28.73 1/15/20248,250,000 shares $236.03 million -4.2%N/A9.3 $28.61 12/31/20238,610,000 shares $258.04 million -6.5%N/A9.7 $29.97 12/15/20239,210,000 shares $260.74 million +0.9%N/A10 $28.31 11/30/20239,130,000 shares $213.00 million +0.4%N/A6.7 $23.33Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the September 1st funding windo 11/15/20239,090,000 shares $198.53 million +0.4%N/A7 $21.84 10/31/20239,050,000 shares $163.81 million +0.7%N/A7.2 $18.10 10/15/20238,990,000 shares $157.77 million -6.5%N/A7.6 $17.55 9/30/20239,610,000 shares $196.91 million +6.7%N/A8.3 $20.49 9/15/20239,010,000 shares $211.28 million +24.5%N/A8.2 $23.45 8/31/20237,240,000 shares $113.31 million -6.2%N/A12 $15.65 8/15/20237,720,000 shares $125.37 million -1.0%N/A11.9 $16.24 7/31/20237,800,000 shares $140.79 million -2.1%N/A11.6 $18.05 7/15/20237,970,000 shares $157.17 million -2.9%N/A11.6 $19.72 6/30/20238,210,000 shares $163.13 million -1.9%N/A11.8 $19.87 6/15/20238,370,000 shares $190.42 million +6.0%N/A10.9 $22.75 5/31/20237,900,000 shares $165.35 million -2.5%N/A9.7 $20.93 5/15/20238,100,000 shares $176.34 million +0.9%N/A9.8 $21.77 4/30/20238,030,000 shares $143.90 million -2.3%N/A9.6 $17.92 4/15/20238,220,000 shares $146.64 million -9.3%N/A9.7 $17.84 3/31/20239,060,000 shares $155.20 million +1.5%N/A10.5 $17.13 3/15/20238,930,000 shares $160.83 million +7.5%N/A9.5 $18.01 2/28/20238,310,000 shares $159.64 million +9.9%N/A9.2 $19.21 2/15/20237,560,000 shares $148.33 million +11.0%N/A8.6 $19.62 1/31/20236,810,000 shares $147.98 million -8.1%N/A7.5 $21.73 1/15/20237,410,000 shares $165.76 million +5.3%N/A8.1 $22.37 12/30/20227,040,000 shares $137.77 million +0.1%N/A7.7 $19.57 12/15/20227,030,000 shares $154.80 million -7.9%N/A6.8 $22.02 11/30/20227,630,000 shares $144.05 million -2.3%N/A7.6 $18.88 11/15/20227,810,000 shares $161.67 million -16.9%N/A7.8 $20.70 10/31/20229,400,000 shares $175.40 million -0.5%N/A9.7 $18.66 10/15/20229,450,000 shares $154.41 million -16.4%15.5%9.7 $16.34 9/30/202211,300,000 shares $180.35 million -3.9%18.5%11.7 $15.96 9/15/202211,760,000 shares $183.22 million +8.3%19.2%13.5 $15.58 8/31/202210,860,000 shares $167.35 million +1.1%17.8%14.2 $15.41 8/15/202210,740,000 shares $196.76 million +18.9%17.6%13.1 $18.32 7/31/20229,030,000 shares $130.94 million +5.2%14.8%9.8 $14.50 7/15/20228,580,000 shares $138.31 million +4.0%14.1%9.7 $16.12 6/30/20228,250,000 shares $113.52 million +4.2%13.6%9.7 $13.76 6/15/20227,920,000 shares $86.96 million -4.6%13.0%10.2 $10.98 5/31/20228,300,000 shares $98.36 million +10.1%13.7%12 $11.85 5/15/20227,540,000 shares $68.54 million -0.3%12.4%12.9 $9.09 4/30/20227,560,000 shares $77.72 million -12.6%12.6%15.2 $10.28 4/15/20228,650,000 shares $117.29 million -1.3%14.5%18.3 $13.56 3/31/20228,760,000 shares $138.93 million +3.8%14.7%19.2 $15.86 3/15/20228,440,000 shares $116.30 million +2.1%14.1%15.7 $13.78 2/28/20228,270,000 shares $147.29 million +1.2%14.0%15.2 $17.81 2/15/20228,170,000 shares $163.40 million +4.6%13.8%15.2 $20.00 1/31/20227,810,000 shares $129.96 million -9.2%13.8%14.5 $16.64 1/15/20228,600,000 shares $161.42 million +9.3%14.1%17 $18.77 12/31/20217,870,000 shares $171.80 million -2.6%12.9%16.9 $21.83 12/15/20218,080,000 shares $186.73 million +4.5%13.2%20.6 $23.11 11/30/20217,730,000 shares $188.84 million +0.7%12.6%22.2 $24.43 11/15/20217,680,000 shares $198.91 million -2.5%12.5%20.8 $25.90 10/29/20217,880,000 shares $234.11 million +0.9%12.8%20 $29.71Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the September 1st funding windo 10/15/20217,810,000 shares $218.06 million -3.6%12.7%18.4 $27.92 9/30/20218,100,000 shares $242.11 million +2.4%13.1%17.6 $29.89 9/15/20217,910,000 shares $269.34 million +0.1%12.8%16.9 $34.05 8/31/20217,900,000 shares $270.26 million +2.3%12.8%17.2 $34.21 8/13/20217,720,000 shares $230.98 million -3.7%12.7%18.7 $29.92 7/30/20218,020,000 shares $287.28 million +5.3%13.2%20.4 $35.82 7/15/20217,620,000 shares $326.90 million -0.4%12.6%21.2 $42.90 6/30/20217,650,000 shares $338.82 million -4.0%12.6%21.8 $44.29 6/15/20217,970,000 shares $370.61 million -1.1%13.1%20.1 $46.50 5/28/20218,060,000 shares $342.55 million -1.0%13.3%18.6 $42.50 5/14/20218,140,000 shares $333.25 million +2.3%N/A17.3 $40.94 4/30/20217,960,000 shares $368.15 million -3.2%N/A16 $46.25 4/15/20218,220,000 shares $357.82 million -6.7%N/A16.7 $43.53 3/31/20218,810,000 shares $381.83 million +7.2%N/A17.3 $43.34 3/15/20218,220,000 shares $440.76 million -0.4%N/A15.7 $53.62 2/26/20218,250,000 shares $427.85 million +0.7%N/A11.2 $51.86 2/12/20218,190,000 shares $489.11 million -1.3%N/A11.2 $59.72 1/29/20218,300,000 shares $453.01 million +0.7%N/A11.5 $54.58 1/15/20218,240,000 shares $480.97 million +0.1%N/A11.9 $58.37 12/31/20208,230,000 shares $461.29 million -10.8%N/A12.3 $56.05 12/15/20209,230,000 shares $517.53 million +1.5%N/A14.8 $56.07 11/30/20209,090,000 shares $291.24 million -0.6%N/A19.9 $32.04 11/15/20209,140,000 shares $292.21 million -5.8%N/A30.3 $31.97 10/30/20209,700,000 shares $279.65 million +0.6%N/A35.5 $28.83 10/15/20209,640,000 shares $268.76 million +0.8%N/A34.6 $27.88 9/30/20209,560,000 shares $218.54 million +0.5%N/A32 $22.86 9/15/20209,510,000 shares $230.81 million +0.4%N/A25.9 $24.27 8/31/20209,470,000 shares $242.15 million -0.3%N/A23.1 $25.57 8/14/20209,500,000 shares $261.16 million +2.6%N/A22.1 $27.49 RCKT Short Interest - Frequently Asked Questions What is Rocket Pharmaceuticals' current short interest? Short interest is the volume of Rocket Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 12,900,000 shares of RCKT short. Learn More on Rocket Pharmaceuticals' current short interest. What is a good short interest ratio for Rocket Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RCKT shares currently have a short interest ratio of 3.0. Learn More on Rocket Pharmaceuticals's short interest ratio. Which institutional investors are shorting Rocket Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Rocket Pharmaceuticals: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Rocket Pharmaceuticals' short interest increasing or decreasing? Rocket Pharmaceuticals saw a decrease in short interest during the month of July. As of July 15th, there was short interest totaling 12,900,000 shares, a decrease of 5.0% from the previous total of 13,580,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Rocket Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Rocket Pharmaceuticals: Harrow, Inc. (11.31%), WAVE Life Sciences Ltd. (10.31%), Cidara Therapeutics, Inc. (12.98%), CureVac N.V. (1.11%), Aurinia Pharmaceuticals Inc (8.91%), Phibro Animal Health Corporation (4.11%), Praxis Precision Medicines, Inc. (10.65%), Sana Biotechnology, Inc. (27.79%), Arcus Biosciences, Inc. (15.55%), Dyne Therapeutics, Inc. (11.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Rocket Pharmaceuticals stock? Short selling RCKT is an investing strategy that aims to generate trading profit from Rocket Pharmaceuticals as its price is falling. RCKT shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Rocket Pharmaceuticals? A short squeeze for Rocket Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RCKT, which in turn drives the price of the stock up even further. How often is Rocket Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RCKT, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies Harrow Short Squeeze WAVE Life Sciences Short Squeeze Cidara Therapeutics Short Squeeze CureVac Short Squeeze Aurinia Pharmaceuticals Short Squeeze Phibro Animal Health Short Squeeze Praxis Precision Medicines Short Squeeze Sana Biotechnology Short Squeeze Arcus Biosciences Short Squeeze Dyne Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RCKT) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredThe Day Silicon DiesThe Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...The Oxford Club | SponsoredThis accelerated income plan is solving American's #1 retirement fearThe #1 fear in retirement today? Running out of money. That’s why income expert Tim Plaehn created a simple...Investors Alley | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RCKT Stock Alerts